Hoersholm, 2013-01-03 14:02 CET (GLOBE NEWSWIRE) --
Company announcement no.1/2013
At the Annual General Meeting of Chr. Hansen Holding A/S held on Tuesday, 27 November 2012, it was decided to reduce the Company's share capital with nominally DKK 35,342,440 from DKK 1,380,342,200 to DKK 1,344,999,760 by cancellation of 3,534,244 treasury shares of DKK 10 each acquired under the Company’s share buy-back program.
Chr. Hansen Holding A/S has today registered the completion of the reduction of the share capital with the Danish Business Authority and consequently cancelled nominally DKK 3,534,244 shares. After the reduction of the share capital, the Company's share capital is nominally DKK 1,344,999,760.
For further information, please contact:
Anders Mohr Christensen, Senior Director IR
Tel: +45 4574 7618
Kristine Ahrensbach, Director, Corporate Communications
Tel: +45 4574 7623
About Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products are centered around cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2011/12 financial year was EUR 699 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,450 dedicated employees in over 30 countries. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen. For further information, please visit www.chr-hansen.com.
